DK1453956T3 - Fremgangsmåden til produktion af virusantigen i stor målestok - Google Patents

Fremgangsmåden til produktion af virusantigen i stor målestok

Info

Publication number
DK1453956T3
DK1453956T3 DK02792957T DK02792957T DK1453956T3 DK 1453956 T3 DK1453956 T3 DK 1453956T3 DK 02792957 T DK02792957 T DK 02792957T DK 02792957 T DK02792957 T DK 02792957T DK 1453956 T3 DK1453956 T3 DK 1453956T3
Authority
DK
Denmark
Prior art keywords
production process
virus antigen
antigen production
scale virus
cell culture
Prior art date
Application number
DK02792957T
Other languages
English (en)
Inventor
Manfred Reiter
Wolfgang Mundt
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21723079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1453956(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Application granted granted Critical
Publication of DK1453956T3 publication Critical patent/DK1453956T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK02792957T 2001-12-10 2002-12-10 Fremgangsmåden til produktion af virusantigen i stor målestok DK1453956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/006,881 US6951752B2 (en) 2001-12-10 2001-12-10 Method for large scale production of virus antigen
PCT/EP2002/014011 WO2003054174A1 (en) 2001-12-10 2002-12-10 Method for large scale production of virus antigen

Publications (1)

Publication Number Publication Date
DK1453956T3 true DK1453956T3 (da) 2010-01-11

Family

ID=21723079

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02792957T DK1453956T3 (da) 2001-12-10 2002-12-10 Fremgangsmåden til produktion af virusantigen i stor målestok
DK10011842.1T DK2330189T3 (da) 2001-12-10 2002-12-10 Fremgangsmåde til virusproduktion i stor målestok

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10011842.1T DK2330189T3 (da) 2001-12-10 2002-12-10 Fremgangsmåde til virusproduktion i stor målestok

Country Status (18)

Country Link
US (2) US6951752B2 (da)
EP (3) EP1894998A1 (da)
JP (2) JP4370511B2 (da)
CN (2) CN101100657B (da)
AT (1) ATE447010T2 (da)
AU (1) AU2002358662B2 (da)
CA (1) CA2469644C (da)
DE (2) DE122010000025I1 (da)
DK (2) DK1453956T3 (da)
ES (2) ES2335395T5 (da)
FR (1) FR10C0026I1 (da)
HK (2) HK1115609A1 (da)
HU (1) HU225791B1 (da)
MX (1) MXPA04005644A (da)
NO (1) NO20042910L (da)
PL (1) PL208232B1 (da)
RU (1) RU2314344C2 (da)
WO (1) WO2003054174A1 (da)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
BRPI0215003B1 (pt) * 2001-12-20 2017-03-14 Bavarian Nordic As método para a recuperação e purificação de poxvírus a partir de células infectadas
NZ538575A (en) 2002-09-05 2007-03-30 Bavarian Nordic As Method for the amplification of a virus wherein primary avian cells are cultivated in a serum-free medium comprising growth factors and attachment factors
JP4541157B2 (ja) * 2002-12-23 2010-09-08 ブリストル−マイヤーズ スクイブ カンパニー タンパク質を製造するための哺乳類細胞培養法
JP2007515172A (ja) * 2003-12-23 2007-06-14 シェーリング　コーポレイション 無血清培地懸濁培養において安定なａ５４９細胞株を生成するための方法
EP1780269B1 (en) 2004-02-23 2009-07-08 Crucell Holland B.V. Virus purification methods
WO2005103235A1 (ja) * 2004-04-19 2005-11-03 Denka Seiken Co., Ltd. ウイルスの生産方法
AU2005245943A1 (en) * 2004-05-20 2005-12-01 Id Biomedical Corporation Process for the production of an influenza vaccine
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
KR101260084B1 (ko) 2004-12-23 2013-05-03 메디뮨 엘엘씨 바이러스의 증식을 위한 비종양형성성 ｍｄｃｋ 세포주
JP2009532352A (ja) 2006-03-31 2009-09-10 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション ワクチンのための高力価組み換えインフルエンザ・ウィルス
RU2487935C2 (ru) 2006-09-15 2013-07-20 Медиммун, Ллк. Линии клеток почки собаки майдин-дэрби (mdck), поддерживающие рост вирусов до высоких титров, и способ применения этих клеток в биореакторе
JP5084214B2 (ja) * 2006-09-29 2012-11-28 一般財団法人日本ポリオ研究所 Ｉｐｖワクチン
BRPI0811533A2 (pt) * 2007-05-04 2014-10-14 Baxter Int Método para a produção de um vírus
US9474798B2 (en) 2007-06-18 2016-10-25 Wisconsin Alumni Research Foundation Influenza M2 protein mutant viruses as live influenza attenuated vaccines
WO2009114693A1 (en) * 2008-03-12 2009-09-17 Wyeth Method for identifying cells suitable for large-scale production of recombinant proteins
RU2011107757A (ru) * 2008-08-01 2012-09-10 Гамма Ваксинс Пти Лимитед (Au) Вакцины против гриппа
CN102216450B (zh) * 2008-09-24 2014-05-14 米迪缪尼有限公司 培养细胞、增殖和纯化病毒的方法
WO2010036774A1 (en) 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
WO2011014416A2 (en) 2009-07-31 2011-02-03 Xcellerex, Inc. High yield yellow fever virus strain with increased propagation in cells
US9109013B2 (en) 2009-10-26 2015-08-18 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in vero cells
JP5894929B2 (ja) * 2009-12-23 2016-03-30 サノフィ・パスツールＳａｎｏｆｉｐａｓｔｅｕｒ 接着細胞の培養方法
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
WO2011130119A2 (en) 2010-04-14 2011-10-20 Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
CN101979517B (zh) * 2010-10-15 2011-12-28 普莱柯生物工程股份有限公司 一种利用生物反应器大规模生产流感病毒的方法
US20140079732A1 (en) 2011-01-27 2014-03-20 Gamma Vaccines Pty Limited Combination vaccines
CN102492659A (zh) * 2011-11-14 2012-06-13 成都康华生物制品有限公司 一种疫苗生产用甲肝病毒的生产方法
US9950057B2 (en) 2013-07-15 2018-04-24 Wisconsin Alumni Research Foundation (Warf) High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
CN103387958B (zh) * 2013-08-16 2016-04-06 北京科兴中维生物技术有限公司 人胚肺成纤维细胞sv-7在病毒培养中的应用
JP6633522B2 (ja) 2013-11-16 2020-01-22 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
CA2969197C (en) 2015-01-26 2020-08-18 Ube Industries, Ltd. Method, device and kit for mass cultivation of cells using polyimide porous membrane
SG11201706066RA (en) 2015-01-26 2017-08-30 Ube Industries Method of producing substance
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US9890363B2 (en) 2015-07-06 2018-02-13 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
JP2019510481A (ja) 2016-02-19 2019-04-18 ウィスコンシン アルムニ リサーチ ファンデイション ワクチン開発のための改善されたｂ型インフルエンザウイルス複製
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US20190264156A1 (en) 2016-07-25 2019-08-29 Ube Industries, Ltd. Siphon type cultivation method
EP3489348A4 (en) 2016-07-25 2020-04-15 UBE Industries, Ltd. CELL CULTURE MODULE
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
WO2019143291A1 (en) * 2018-01-18 2019-07-25 Yisheng Biopharma (Singapore) Pte. Ltd. Method for adapting influenza viruses to vero cells
SG11202007503WA (en) 2018-02-07 2020-09-29 Bharat Biotech Int Ltd A process for enterovirus purification and inactivation and vaccine compositions obtained thereof
JP2022527235A (ja) 2019-01-23 2022-06-01 義裕 河岡 インフルエンザウイルスにおける付加的遺伝子に遺伝的安定性を付与する突然変異
KR102228267B1 (ko) * 2019-01-25 2021-03-17 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
WO2020153619A1 (ko) * 2019-01-25 2020-07-30 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
US11851648B2 (en) 2019-02-08 2023-12-26 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US11390649B2 (en) 2019-05-01 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
TW202122569A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 應用小片多孔膜的細胞培養法
TW202122572A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 胞外體的產生方法
EP4022046A2 (en) 2019-08-27 2022-07-06 Wisconsin Alumni Research Foundation (WARF) Recombinant influenza viruses with stabilized ha for replication in eggs
CN111850169B (zh) * 2020-07-16 2022-09-27 华农（肇庆）生物产业技术研究院有限公司 一种计算AIV在MDCK-sus细胞中细胞单位均产毒量的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525349A (en) 1981-12-29 1985-06-25 Societe Anonyme Dite: Institut Merueux Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine
AT393356B (de) 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
FR2723740B1 (fr) 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
ES2378409T3 (es) 1994-11-10 2012-04-12 Baxter Healthcare S.A. Método para producir sustancias biológicas en cultivo sin proteínas
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB2319413B (en) * 1996-11-12 2001-06-06 Lsi Logic Corp Driver circuits
AU6028898A (en) * 1997-01-31 1998-08-25 Schering Corporation Methods for cultivating cells and propagating viruses
US6168944B1 (en) * 1997-01-31 2001-01-02 Schering Corporation Methods for cultivating cells and propagating viruses
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus

Also Published As

Publication number Publication date
MXPA04005644A (es) 2005-04-19
US20050181495A1 (en) 2005-08-18
HK1158691A1 (en) 2012-07-20
JP5021000B2 (ja) 2012-09-05
HUP0402415A3 (en) 2005-07-28
DE60234211D1 (de) 2009-12-10
CN101100657A (zh) 2008-01-09
EP2330189A1 (en) 2011-06-08
CA2469644A1 (en) 2003-07-03
HUP0402415A2 (hu) 2005-02-28
EP1453956B8 (en) 2010-02-10
ATE447010T2 (de) 2009-11-15
AU2002358662A1 (en) 2003-07-09
HK1115609A1 (en) 2008-12-05
EP1894998A8 (en) 2008-04-23
EP2330189B1 (en) 2014-05-21
US7524676B2 (en) 2009-04-28
DK2330189T3 (da) 2014-06-16
RU2314344C2 (ru) 2008-01-10
US6951752B2 (en) 2005-10-04
CN101100657B (zh) 2012-05-30
ES2335395T5 (es) 2017-08-31
AU2002358662B2 (en) 2008-05-15
PL208232B1 (pl) 2011-04-29
CA2469644C (en) 2013-07-23
EP1453956A1 (en) 2004-09-08
RU2004121178A (ru) 2005-10-10
US20030108860A1 (en) 2003-06-12
ES2488818T3 (es) 2014-08-29
CN100335619C (zh) 2007-09-05
FR10C0026I1 (fr) 2011-01-14
JP2009261410A (ja) 2009-11-12
JP2005512564A (ja) 2005-05-12
EP1453956B2 (en) 2017-01-18
ES2335395T3 (es) 2010-03-26
JP4370511B2 (ja) 2009-11-25
NO20042910L (no) 2004-07-09
PL373487A1 (en) 2005-09-05
DE122010000025I1 (de) 2010-08-12
WO2003054174A1 (en) 2003-07-03
EP1453956B1 (en) 2009-10-28
CN1617924A (zh) 2005-05-18
HU225791B1 (en) 2007-09-28
EP1894998A1 (en) 2008-03-05

Similar Documents

Publication Publication Date Title
DK1453956T3 (da) Fremgangsmåden til produktion af virusantigen i stor målestok
ID28122A (id) Fermenter keadaan padat dan prosedur untuk fermentasi keadaan dapat
DE60043534D1 (de) VERFAHREN UND VORRICHTUNG ZUR HALTUNG UND EXPANSION VON HEMATOPOIETISCHEN STAMMZELLEN UND/ODER VORLäUFERZELLEN
DK1651758T3 (da) Fremgangsmåde tl fremstilling af L-lysin eller L-threonin ved anvendelse af Escherichia bakterier med svækket æblesyreenzymaktivitet
ATE383417T1 (de) Produktion lymphoider gewebsspezifischer zellen von hämatopoietischen vorläuferzellen in einem dreidimensionalen system
WO2005072254A3 (en) Modulation of sulfate permease for photosynthetic hydrogen production
ES2076944T3 (es) Procedimiento para el cultivo de bacterias.
DE60138029D1 (de) Verfahren zur herstellung von biopterinen
MXPA03000846A (es) Metodo para producir reovirus infecciosos.
DK1495112T3 (da) Cellekulturmedium
CY1111253T1 (el) Μεθοδος για την παραγωγη ιικου υλικου
ATE364711T1 (de) C3a serumfreie klonale zell-linie sowie deren anwendungen
WO2000077236A3 (en) Methods for enhancing the production of cytokines in cell cultur e
DK1456238T3 (da) Produktion af F(ab')2-fragmenter i pattedyrceller
FI890980A (fi) Organiskt polymermaterial och jonbytesmembran framstaelld daerav.
ATE393806T1 (de) Verfahren zur güllebehandlung
DE60032791D1 (de) Test für mikroorganismen in zellkulturen
DK1297106T3 (da) Reaktormodul med kapilærmembraner
DE50102904D1 (de) Anordnung zur Befestigung von Plattenmaterial, insbesondere von Glasscheiben, an Standsäulen oder dergleichen
ATE491036T1 (de) Herstellung von optisch aktiven alkoholen mit ganzzellenkatalysatoren
Dianati Tilaki et al. Carbon Dioxide Removal and Biomass Production from Methane Combustion in the Photobioreactor using Microalgae Spirulina
ATE423841T1 (de) Verwendung von glutaminfreien medium
WO2024019516A1 (ko) 미세조류 배양방법
CN2522414Y (zh) 微穴组合片型填料
ATA152783A (de) Anlage fuer die anaerobe gaerung faulfaehiger substanzen, insbesondere zur erzeugung von biomethangas